The artificial kidney market comprises medical devices that replace the functions of the kidney in people with renal failure. Artificial kidneys assist patients suffering from kidney diseases by filtering waste and excess fluids from the blood through a process known as hemodialysis. They help remove toxins and excess water from the blood outside the body. The growing prevalence of chronic kidney diseases and end-stage renal disease has increased the demand for renal replacement therapies like dialysis. As per statistics, around 786,000 and 2.2 million people suffer from kidney failure in the U.S. and China respectively. The deficiency in organ donations for kidney transplants has encouraged the adoption of advanced dialysis treatments.
The Global artificial kidney market is estimated to be valued at US$ 3358.54 Mn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the artificial kidney market are KAWASUMI LABORATORIES, INC., Nanodialysis, Fresenius SE Co KGaA, Baxter, ASAHI KASEI MEDICAL CO., LTD, Medtronic, DaVita Inc, Merit Medical Systems, Nipro Medical Corporation, Nikkiso Co Ltd, Braun Melsungen AG and AWAK Technologies. These players are focusing on new product launches and strategic collaborations to gain more market share.
There is a significant rise in research and development activities to develop innovative bioartificial kidneys that can effectively mimic the functions of a real kidney. Companies are investing heavily in developing miniature implantable biohybrid technologies that can eliminate the need for frequent hemodialysis sessions.
The artificial kidney market players are expanding their geographical presence across major markets to tap the increasing demand for renal replacement therapies globally. They have adopted organic and inorganic growth strategies like acquisitions, partnerships, and joint ventures to establish manufacturing and distribution facilities in developing regions.
Market drivers: The rising prevalence of lifestyle diseases augmenting the incidence of chronic kidney disease is a major factor driving the artificial kidney market growth. Also, the growing geriatric population who are more prone to renal disorders contributes to market expansion.
Market restraints: However, the high cost associated with dialysis procedures limits widespread adoption. Additionally, the lack of organ donors and sophisticated medical infrastructure in underdeveloped countries hinders market penetration.
Segment Analysis
The artificial kidney market is dominated by the hemodialysis sub segment. Hemodialysis remains the most widely used treatment for kidney failure and end stage renal diseases across the globe. It accounts for over 95% of the overall market share as it is effective and less invasive treatment compared to peritoneal dialysis. Hemodialysis segment is expected to continue its dominance during the forecast period due to rising prevalence of chronic kidney diseases and increasing demand for kidney replacement therapies.
Global Analysis
The North America region holds the major share in the artificial kidney market and is expected to continue its dominance during the forecast period. This is attributed to the rapidly growing aging population, rising healthcare expenditure, increasing prevalence of chronic kidney diseases and presence key players in the region. The Asia Pacific market is estimated to witness the highest growth rate during the forecast period due to growing awareness regarding renal diseases, development of healthcare infrastructure and rising medical tourism in the emerging countries of the region.
